Cita APA

Mariner-Llicer, C., Saavedra Cervera, B., Mambuque, E., Gomes, N., Munguambe, S., Villamayor, L. M., . . . García-Basteiro, A. L. (2024). Monitoring of first-line drug resistance mutations outside the scope of Xpert MTB/RIF Ultra is needed for successful control of DR-TB in Southern Mozambique.

Citación estilo Chicago

Mariner-Llicer, Carla, et al. Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra Is Needed for Successful Control of DR-TB in Southern Mozambique. 2024.

Cita MLA

Mariner-Llicer, Carla, et al. Monitoring of First-line Drug Resistance Mutations Outside the Scope of Xpert MTB/RIF Ultra Is Needed for Successful Control of DR-TB in Southern Mozambique. 2024.